Second phase III trial of MED2002 for the Treatment of Erectile Dysfunction (ED)

Trial Profile

Second phase III trial of MED2002 for the Treatment of Erectile Dysfunction (ED)

Planning
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Nitroglycerin (Primary)
  • Indications Erectile dysfunction
  • Focus Registrational; Therapeutic Use
  • Sponsors Futura Medical
  • Most Recent Events

    • 01 Dec 2017 New trial record
    • 29 Nov 2017 According to a Futura Medical media release, data from the PK study (profile 283168) will determine the dosages to be used in this and other trial (see profile 283164).
    • 29 Nov 2017 According to a Futura Medical media release, the Medicines and Healthcare products Regulatory Agency and the Medicines Evaluation Board has approved two Phase III trials (this and profile 283164) and one pharmacokinetic trial (see profile 283168).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top